Abvc Biopharma, Inc.

ABVC Nasdaq SEC CIK 1173313
Follow Abvc Biopharma Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income $1.1M +156.3% vs same quarter last year
EPS, diluted $0.04 +144.4% vs same quarter last year
Operating cash flow −$438.9K +54.5% vs same quarter last year
Operating income −$1.2M +36.8% vs same quarter last year
Revenue by quarter
$2K
$796K
Q4 24 Q3 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$20M−$15M−$10M−$5M$0$5MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$296K−$7.9M
FY24$509.6K−$4.9M
FY23$152.4K−$7.8M
FY22$969.8K−$16.4M
FY21$355.8K−$12.8M
FY20$483K−$10.6M
FY19$701.7K−$3.9M
FY18$7K−$6.1M
FY17-−$4.2M
FY16-−$11M
FY15$3.4K−$32.3K
FY14$0−$70
FY13$7.8K−$226.4K
FY12$5.7K−$1.1M
FY11$3.2K−$1.2M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100000%−75000%−50000%−25000%0%25000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25-−2416%−2671.8%
FY2499.9%−923.3%−962.1%
FY23−98.1%−4439.2%−5109.3%
FY2270.5%−1558.5%−1693.5%
FY2198.6%−3290.1%−3608.5%
FY2096.1%−1760.9%−2193.1%
FY1997.1%−492.9%−560.5%
FY18−2563.6%−40031.1%−87184.2%
FY17---
FY16---
FY1584.5%-−960.7%
FY14---
FY13-−2276.3%−2906.8%
FY12-−20004.3%−18718.6%
FY11-−59180.7%−38202.2%
Free cash flowOperating cash flow minus capital expenditure
−$8M−$6M−$4M−$2M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23−$4.2M
FY22−$7.5M
FY21−$7.6M
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
FY14-
FY13−$37.8K
FY12−$915.5K
FY11−$1.6M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Abvc Biopharma
  • Healthcare median
−100000%−75000%−50000%−25000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearAbvc BiopharmaHealthcare median
FY25−2671.8%−30.6%
FY24−962.1%−47%
FY23−5109.3%−58%
FY22−1693.5%−80.4%
FY21−3608.5%−71.8%
FY20−2193.1%−62.2%
FY19−560.5%−46.2%
FY18−87184.2%−49.6%
FY17-−45.9%
FY16-−36%
FY15−960.7%−37.8%
FY14-−35.5%
FY13−2906.8%−37.1%
FY12−18718.6%−29.1%
FY11−38202.2%−27.9%